ALAPIS Α.Β.Ε.Ε.
Announcement regarding: A) The listing of shares, from the Company's stock reverse split and B) The change of Company Name.
ALAPIS SA, informs the investment community that the Ordinary General Shareholders meeting dated 28/05/2010 approved among other issues:
A)The increase of the nominal value of each share from 0.30 euro to 2.40 euro and at the same time the reduction of the total number of existing shares from 1,961,200,440 to 245,150,055 common registered shares (reverse split), with a ratio of 1 new share in replacement of 8 existing shares.
Pursuant to the above, the company's share capital amounts to 588,360,132 euro, divided into 245,150,055 shares of nominal value 2.40 euro per share.
B) The change of the company's name to "ALAPIS HOLDING INDUSTRIAL AND COMMERCIAL SOCIETE ANONYME OF PHARMACEUTICAL AND CHEMICAL PRODUCTS" with the distinctive title remaining as in effect, namely "ALAPIS SA".
On 15/06/2010 the decision No.K2-5113/14.06.2010 by the Ministry of Finance, Competition and Shipping, which approved the amendment of the respective articles of the Company's Articles of Association, was registered with the Prefecture of Athens Registry of Public Companies.
The Athens Exchange Board of Directors, at its session dated 24/06/2010:
A) Approved the floating at the Exchange of the above 245,150,055 new shares of a nominal value of 2.40 euro each in replacement of the existing 1,961,200,440 common registered shares.
According to the company's decision, 29/06/2010 will be the last trading day of the 1,961,200,440 existing company's common registered shares. As of the following trading day 30/06/2010, the trading of the company's shares will cease temporarily in order for the completion of the replacement process, pursuant to the aforementioned.
The beneficiaries of the above corporate action are the shareholders who will be registered in the DSS archives as regards the aforementioned listed company as at 02/07/2010.
07/07/2010, will be the first floating date of the 245,150,055 new shares with the new nominal value 2.40 per share at the Athens Exchange. As of that date the new total outstanding company's number of shares listed on the ATHEX will amount 245,150,055 common registered shares, the initial share price at the ATHEX will be determined according to the Athens Exchange Rulebook, as well as the Athens Exchange BoD decision No 26 as in effect and the new shares will be credited to the Shareholders' Share account and Securities Account registered with the Dematerialized Securities System (D.S.S.).
B) Was informed of the Change of Company Name. By virtue of the company's decision, it is set that as of 07/07/2010, the Company's name at the Athens Exchange changes to "ALAPIS HOLDING INDUSTRIAL AND COMMERCIAL SOCIETE ANONYME OF PHARMACEUTICAL AND CHEMICAL PRODUCTS" with the distinctive title "ALAPIS SA".
For further information please contact the company's Investor Relations Department (tel. +30 213-017 5000/-1).
A)The increase of the nominal value of each share from 0.30 euro to 2.40 euro and at the same time the reduction of the total number of existing shares from 1,961,200,440 to 245,150,055 common registered shares (reverse split), with a ratio of 1 new share in replacement of 8 existing shares.
Pursuant to the above, the company's share capital amounts to 588,360,132 euro, divided into 245,150,055 shares of nominal value 2.40 euro per share.
B) The change of the company's name to "ALAPIS HOLDING INDUSTRIAL AND COMMERCIAL SOCIETE ANONYME OF PHARMACEUTICAL AND CHEMICAL PRODUCTS" with the distinctive title remaining as in effect, namely "ALAPIS SA".
On 15/06/2010 the decision No.K2-5113/14.06.2010 by the Ministry of Finance, Competition and Shipping, which approved the amendment of the respective articles of the Company's Articles of Association, was registered with the Prefecture of Athens Registry of Public Companies.
The Athens Exchange Board of Directors, at its session dated 24/06/2010:
A) Approved the floating at the Exchange of the above 245,150,055 new shares of a nominal value of 2.40 euro each in replacement of the existing 1,961,200,440 common registered shares.
According to the company's decision, 29/06/2010 will be the last trading day of the 1,961,200,440 existing company's common registered shares. As of the following trading day 30/06/2010, the trading of the company's shares will cease temporarily in order for the completion of the replacement process, pursuant to the aforementioned.
The beneficiaries of the above corporate action are the shareholders who will be registered in the DSS archives as regards the aforementioned listed company as at 02/07/2010.
07/07/2010, will be the first floating date of the 245,150,055 new shares with the new nominal value 2.40 per share at the Athens Exchange. As of that date the new total outstanding company's number of shares listed on the ATHEX will amount 245,150,055 common registered shares, the initial share price at the ATHEX will be determined according to the Athens Exchange Rulebook, as well as the Athens Exchange BoD decision No 26 as in effect and the new shares will be credited to the Shareholders' Share account and Securities Account registered with the Dematerialized Securities System (D.S.S.).
B) Was informed of the Change of Company Name. By virtue of the company's decision, it is set that as of 07/07/2010, the Company's name at the Athens Exchange changes to "ALAPIS HOLDING INDUSTRIAL AND COMMERCIAL SOCIETE ANONYME OF PHARMACEUTICAL AND CHEMICAL PRODUCTS" with the distinctive title "ALAPIS SA".
For further information please contact the company's Investor Relations Department (tel. +30 213-017 5000/-1).